
|Articles|June 2, 2020
UCB and N-SIDE Increase Strategic Collaboration
Advertisement
N-SIDE has announced that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization. With this new agreement, UCB will use the N-SIDE Suite for Clinical Trials solution and N-SIDE consulting services. N-SIDE and UCB have had a consulting agreement in place since 2012.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5




